Literature DB >> 3964083

Biocompatibility of haemoperfusion.

J H Rommes, B Sangster, L Berrens, C Borst, A N van Heijst.   

Abstract

To evaluate the influence of haemoperfusion on haemodynamics, complement system, leucocyte and thrombocyte concentration, a controlled study was performed in three groups of five dogs each. During the first 30 min of haemoperfusion with columns containing cellulose-coated activated charcoal, a significant decrease of mean aortic pressure, cardiac output and stroke volume was observed, while heart rate and total systemic resistance decreased. A comparable phenomenon, although to a much lesser extent, was observed during perfusion using columns containing polystyrene resin. Perfusion with columns containing cellulose-coated activated charcoal caused a significant decrease in total haemolytic complement, indicating activation of the complement system. A significant decrease in the leucocyte and thrombocyte concentration due to sequestration of granulocytes and thrombocytes in the columns was observed during the first 30 min of perfusion in both groups. Pulmonary leucostasis, without decrease of arterial oxygen tension, occurred during perfusion with columns containing cellulose-coated activated charcoal. Both the simultaneous occurrence and the transient character of the haemodynamic changes, complement activation and sequestration of granulocytes and thrombocytes in the perfusion column suggest a relationship between these various changes. The results stress the importance of close monitoring of the haemodynamic parameters of the intoxicated patient, particularly during the early phase of haemoperfusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3964083     DOI: 10.1007/bf00340980

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  [The pros and cons of haemoperfusion (author's transl)].

Authors:  H Hennemann; I E Richter; D Brunswig; A Röckel; J Kult; W Gattenlöhner; A Heidland
Journal:  Klin Wochenschr       Date:  1977-06-01

2.  Hemodynamic evaluation of hypotension during chronic hemodialysis.

Authors:  I Azancot; P Degoulet; Y Juillet; J Rottembourg; M Legrain
Journal:  Clin Nephrol       Date:  1977-07       Impact factor: 0.975

3.  Hemodynamic changes during sequential ultrafiltration and dialysis.

Authors:  B Wehle; H Asaba; J Castenfors; P Fürst; B Gunnarsson; S Shaldon; J Bergström
Journal:  Kidney Int       Date:  1979-04       Impact factor: 10.612

4.  Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.

Authors:  D E Chenoweth; A K Cheung; L W Henderson
Journal:  Kidney Int       Date:  1983-12       Impact factor: 10.612

5.  Nonvagally mediated bradycardia during cardiac tamponade or severe hemorrhage.

Authors:  D R Kostreva; A Castaner; D H Pedersen; J P Kampine
Journal:  Cardiology       Date:  1981       Impact factor: 1.869

6.  The influence of haemoperfusion on haemostasis and cellular constituents of the blood in the treatment of intoxications: a comparative study of three types of columns (Haemocol, Amberlite XAD-4, Gambro Adsorba 300 C).

Authors:  B Sangster; A N van Heijst; J J Sixma
Journal:  Arch Toxicol       Date:  1981-07       Impact factor: 5.153

7.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

8.  The treatment of severe drug intoxication with charcoal hemoperfusion in series with hemodialysis.

Authors:  C Bentley; C M Kjellstrand
Journal:  J Dial       Date:  1979

9.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

Authors:  E H Vallota; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.